Cotreatment with a chemosensitizer such as compounds 39a and 39b (Figure 13) and TRAIL was found to be more efficient to treat GBM (Glioblastoma Multiforme) than treatment with TRAIL alone. This evidence concerns the gene TNFSF10 and glioblastoma.